Pathogenic, immunologic, and clinical aspects of sepsis - update 2016

被引:12
作者
Uhle, Florian [1 ]
Chousterman, Benjamin G. [2 ,3 ]
Gruetzmann, Robert [4 ]
Brenner, Thorsten [1 ]
Weber, Georg F. [4 ]
机构
[1] Univ Heidelberg Hosp, Dept Anesthesiol, Heidelberg, Germany
[2] Hop Lariboisiere, AP HP, Dept Anesthesia Intens Care & SAMU, Paris, France
[3] Univ Paris Diderot, Paris, France
[4] Univ Hosp Erlangen Nurnberg, Dept Surg, Erlangen, Germany
关键词
Bacterial toxins; immune-pathophysiology; sepsis; biomarkers; microbiology; diagnostics; pathogen-host interaction; INTERNATIONAL CONSENSUS DEFINITIONS; INFLAMMATORY RESPONSE SYNDROME; GOAL-DIRECTED RESUSCITATION; NEUTROPHIL RECRUITMENT; INTENSIVE-CARE; SEPTIC SHOCK; IMMUNE-RESPONSE; HOST RESPONSE; DR EXPRESSION; THERAPY;
D O I
10.1080/14787210.2016.1224971
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Introduction: Sepsis is a major cause of death worldwide but its orchestrating components remain incompletely understood. On the one hand, development of sepsis results from an infectious focus that cannot be controlled by the immune system, but on the other, responding immune cells that can eliminate the infection inflict damage to the host by contributing to complications such as endothelial leakage, septic shock, and multiorgan failure.Areas covered: In this review we give a comprehensive overview of how sepsis occurs, which exogenous and endogenous factors might affect the immune-pathophysiological course of sepsis and finally how this knowledge translates into up-to-date definitions and therapeutic approaches.Expert commentary: Although new immunological mechanisms altering the course of sepsis have been identified recently, future research needs to address the limitations of experimental approaches, redirect the research focus into translational approaches, and finally evaluate personalized treatment strategies.
引用
收藏
页码:917 / 927
页数:11
相关论文
共 50 条
[31]   Sepsis-Update: Evidence-based Therapy [J].
Martin, Lukas ;
Bickenbach, Johannes ;
Marx, Gernot .
ANASTHESIOLOGIE INTENSIVMEDIZIN NOTFALLMEDIZIN SCHMERZTHERAPIE, 2019, 54 (01) :50-60
[32]   Internationale Leitlinien der Surviving Sepsis CampaignUpdate 2016International guidelines from the Surviving Sepsis Campaign2016 update [J].
J. Briegel ;
P. Möhnle .
Der Anaesthesist, 2017, 66 :530-538
[33]   Update on surgical sepsis syndrome [J].
Vincent, J. -L. .
BRITISH JOURNAL OF SURGERY, 2017, 104 (02) :E34-E40
[34]   Update on pediatric sepsis: a review [J].
Kawasaki, Tatsuya .
JOURNAL OF INTENSIVE CARE, 2017, 5
[35]   Update on pediatric sepsis: a review [J].
Tatsuya Kawasaki .
Journal of Intensive Care, 5
[36]   Caring for Sepsis Patients: An Update [J].
Shankar-Hari, Manu ;
Singer, Mervyn .
CRITICAL CARE CLINICS, 2018, 34 (01) :XIII-XV
[37]   Immunomodulatory therapy for sepsis: an update [J].
Christaki, Eirini ;
Anyfanti, Panagiota ;
Opal, Steven M. .
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2011, 9 (11) :1013-1033
[38]   Use of Intravenous Immunoglobulins in Sepsis Therapy-A Clinical View [J].
Jarczak, Dominik ;
Kluge, Stefan ;
Nierhaus, Axel .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (15) :1-17
[39]   Autoinflammatory diseases: an update of clinical and genetic aspects [J].
Yao, Q. ;
Furst, D. E. .
RHEUMATOLOGY, 2008, 47 (07) :946-951
[40]   Clinical Update in Pediatric Sepsis: Focus on Children With Pre-Existing Heart Disease [J].
Weiss, Scott L. ;
Nicolson, Susan C. ;
Naim, Maryam Y. .
JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2020, 34 (05) :1324-1332